Trials / Completed
CompletedNCT01516515
Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis
A Double-blind, Randomized, Vehicle-controlled, Parallel-group, Phase II Study to Evaluate the Efficacy and Safety of SR-T100 Gel in Patients With Actinic Keratosis (AK)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 86 (actual)
- Sponsor
- G&E Herbal Biotechnology Co., LTD · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This Phase II study is to evaluate the efficacy of SR-T100 gel with 2.3% of SM in Solanum undatum plant extract in patient with Actinic Keratosis (AK).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vehicle gel | placebo |
| DRUG | SR-T100 with 2.3% of SM | 2.3% of SM in Solanum undatum plant extract |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2017-12-01
- Completion
- 2018-10-01
- First posted
- 2012-01-25
- Last updated
- 2018-12-05
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01516515. Inclusion in this directory is not an endorsement.